Advisor Partners LLC Csl LTD Transaction History

Advisor Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 24, 2020	SELL	$77.9 - $98.54 $886,657 - $1.12 Million	-11,382 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$74.21 - $82.92 $71,686 - $80,100	966 Added 9.27%	11,382 $897,000
Q2 2019 Jul 26, 2019	BUY	$68.24 - $75.87 $59,505 - $66,158	872 Added 9.14%	10,416 $786,000
Q1 2019 Apr 23, 2019	BUY	$65.72 - $71.66 $46,661 - $50,878	710 Added 8.04%	9,544 $661,000
Q4 2018 Jan 29, 2019	BUY	$61.31 - $73.73 $35,498 - $42,689	579 Added 7.01%	8,834 $576,000
Q3 2018 Nov 06, 2018	BUY	$71.66 - $82.93 $101,828 - $117,843	1,421 Added 20.79%	8,255 $601,000
Q2 2018 Jul 25, 2018	BUY	$58.93 - $74.24 $113,086 - $142,466	1,919 Added 39.04%	6,834 $486,000
Q1 2018 May 03, 2018	BUY	$54.51 - $65.8 $267,916 - $323,407	4,915 New	4,915 $293,000

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $85.6B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Advisor Partners LLC with notifications on news.